Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol GRN contributors: mct - updated : 27-02-2015
HGNC name granulin
HGNC id 4601
ASSOCIATED DISORDERS
corresponding disease(s) FTDU17 , CLN11
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral     --over  
in corticoadrenal carcinoma (malignant progression)
constitutional somatic mutation      
mutations creating null alleles cause tau-negative frontotemporal dementia
tumoral     --over  
in uterine leiomyosarcoma
constitutional   deletion    
sufficient to cause neurodegeneration
constitutional   deletion    
deleted with RUNDC3A in frontotemporal dementia
constitutional       loss of function
leads to dysregulated microglial activation and thereby contributes to increased neuron loss with injury
tumoral     --over  
in hepatocellular carcinoma but not in the adjacent non-tumor
constitutional     --low  
in 65 p100 of children with autism
constitutional     --over  
increased GRN in the skin of amyotrophic lateral sclerosis, related to the disease process and metabolic alteration of GRN may take place in the skin of patients with ALS
constitutional     --over  
in Alzheimer disease brains, whereas TMEM106B mRNA levels were decreased
constitutional     --low gain of function
both PSAP reduction and overexpression lead to significantly elevated extracellular GRN levels
Susceptibility
  • to Alzheimer disease and Parkinson disease
  • to frontotemporal lobar degeneration (FTLD)
  • Variant & Polymorphism other
  • mutation frequency of GRN mutation was 6.6p100 in FTLD
  • Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    obesity  
    may be a promising therapeutic target for obesity
    osteoarticular  
    potential target for developing and optimizing the therapeutic application in cartilage repair and arthritic disorders
    cancerdigestiveliver
    potential therapeutic target for HCC
    neurologyneurodegenerative 
    therapeutic target for neurodegenerative diseases including motor neuron disease
    immunologyautoimmunearticular
    promising therapeutic target for rheumatoid arthritis
    ANIMAL & CELL MODELS